The authorities in Serbia and Denmark have now approved the requests for conducting open deliberate release with gene modified Thale Cress.

First North Announcement no. 14  2007/ August 27th, 2007


Copenhagen, August 27th, 2007

Summary: The authorities in Serbia and Denmark have now approved the requests
for conducting open deliberate release with gene modified Thale Cress. 

The plant based biotech company Aresa made an application to the authorities in
Serbia about deliberate release involving open air trials with gene modified
Thale Cress. Thale Cress (Arabidopsis Thaliana) is to be used for detection of
explosives in soil among other in landmines. The Serbian authorities has
evaluated and approved Aresa's application according to local GMO -legislation. 

The deliberate release will take place in an area close to Novi Sad in Serbia,
and will be conducted in cooperation with the agricultural institute NS Seme in
Novi Sad, (See First North announcement #9). The trials will commence
immediately and will continue until end of the current growth season. In order
to maximize the outcome of the deliberate release the trials will also involve
seeding of various eco-types of Thale Cress. In parallel a similar approval has
been given by Skov- og Naturstyrelsen in Denmark for a deliberate release in
Jægerspris (Denmark). 

“The approval is an important milestone in Aresa's further development of the
landmine detection plant RedDetect™. It is important to Aresa to be able to
test the plants outside Denmark, and more importantly in an area, where
landmines do occur and soil conditions are similar to where we potentially are
going to detect landmines and other explosives. We are taking yet another step
towards fulfilling our objective to form a strong plant based bio-tech company”
states Ole Andersen, chairman of the board. 

As an important next step, Aresa expects during the spring of 2008 to have
transferred the RedDetect™ technology to the tobacco plant (Petit Havana), in
order to improve the robustness of RedDetect™ as well as the commercial
potential. NS Seme in Novi Sad has significant expertise related to growing and
refining tobacco plants. 

The content of this message is not expected to have impact on the result for
the current financial year. 

Best regards,

Ole Andersen
Chairman
Aresa A/S


Further information can be obtained by contacting Ole Andersen, Chairman for
Aresa A/S on+45 70227747 or +45 40580214 or to the company's financial advisor
HSH  Corporate Finance A/S, Morten Kjærulff, Director, +45 33449431. 

About Aresa
Aresa is a plant biotech company established in 2001 by the company's current
CSO, Carsten Meier and has origins from the Institute of Molecular Biology at
Copenhagen University. 

Aresa has developed two plant based technology platforms, BioSensor for the
detection of substances in soil, hereunder evaporation of explosives from
landmines; and BioPharma, a tool for the optimisation and production of
antibodies and proteins in plants. 

Aresa was listed on the Copenhagen OMX-First North market place in 2006. Aresa
is based at Symbion Science Park in Copenhagen and has greenhouse facilities in
the outskirts of Copenhagen and test areas in Denmark, Croatia and  Serbia.
Aresa has 16 employees, hereof 8 within research and development and 5 within
landmine operations.